Is non-severe SARS-CoV-2 infection characterized by early T cell proliferation?
The extent of severity of the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), varies from asymptomatic, mild to severe. Scientists found that during the first wave of the pandemic, individuals infected with non-severe SARS-CoV-2, before the onset of the vaccination program, induced effective host-defense mechanisms in naive populations.
To date, little evidence has been documented regarding the immune responses after the onset of the symptoms or virus detection. Further, no cross-sectional studies have been conducted that define the time of infection. Thereby, no report is available that explains the relationship between the earliest immune responses to COVID-19 and temporal kinetics. Scientists believe that understanding the early immune response regarding the asymptomatic or mildly infected population may help determine the factors associate
Global Research Antibodies Market Report 2021: Market to Reach $14 Billion by 2027 - Reagent to Account for $9 4 Billion of the Total Market
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Sepsis Diagnostics Industry Market Insights, Overview, Analysis and Forecast 2020-2026
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.